MYUNGMOON Pharm Co., Ltd.(KR:017180)
â‚©1,017.00-3.00 (-0.29%)
KR:017180
MYUNGMOON Pharm Co., Ltd. financials statements
â‚©1,017.00
At close:-3.00 (-0.29%)
Want to see KR:017180 full AI Analyst Report?
MYUNGMOON Pharm Co., Ltd. (017180) Ratios
MYUNGMOON Pharm Co., Ltd. Ratios
KR:017180's free cash flow for Q3 2026 was ₩-18.51B. For the 2026 fiscal year, KR:017180's free cash flow was decreased by ₩-4.91B and operating cash flow was ₩-13.59B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.96 | 0.87 | 0.70 | 0.64 | 0.60 |
| Quick Ratio | 0.55 | 0.51 | 0.44 | 0.41 | 0.37 |
| Cash Ratio | 0.06 | 0.05 | 0.07 | 0.04 | 0.06 |
| Solvency Ratio | 0.03 | 0.01 | -0.00 | 0.09 | -0.02 |
| Operating Cash Flow Ratio | -0.02 | -0.01 | -0.04 | 0.05 | 0.01 |
| Short-Term Operating Cash Flow Coverage | -0.03 | -0.03 | -0.07 | 0.07 | 0.01 |
| Net Current Asset Value | â‚© -75.93B | â‚© -74.54B | â‚© -66.36B | â‚© -64.48B | â‚© -69.92B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.34 | 0.38 | 0.36 | 0.38 |
| Debt-to-Equity Ratio | 1.00 | 0.90 | 1.08 | 0.93 | 1.05 |
| Debt-to-Capital Ratio | 0.50 | 0.47 | 0.52 | 0.48 | 0.51 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.27 | 0.13 | 0.06 | 0.06 |
| Financial Leverage Ratio | 2.76 | 2.66 | 2.83 | 2.57 | 2.78 |
| Debt Service Coverage Ratio | 0.15 | 0.10 | 0.05 | 0.20 | 0.00 |
| Interest Coverage Ratio | 1.34 | 0.36 | 0.19 | 1.72 | -1.93 |
| Debt to Market Cap | 1.56 | 1.43 | 1.09 | 0.77 | 0.51 |
| Interest Debt Per Share | 3054.91 | 2773.10 | 2839.14 | 2570.32 | 2578.61 |
| Net Debt to EBITDA | 9.16 | 14.65 | 18.23 | 7.41 | 223.87 |
| Profitability Margins | |||||
| Gross Profit Margin | 54.90% | 56.30% | 56.23% | 51.34% | 45.25% |
| EBIT Margin | 3.50% | 0.86% | 0.21% | 4.20% | -2.48% |
| EBITDA Margin | 5.19% | 3.04% | 2.67% | 6.95% | 0.25% |
| Operating Profit Margin | 3.50% | 1.03% | 0.57% | 4.23% | -4.27% |
| Pretax Profit Margin | 1.36% | -2.01% | -2.82% | 1.74% | -4.79% |
| Net Profit Margin | 0.97% | -1.63% | -2.67% | 5.17% | -4.94% |
| Continuous Operations Profit Margin | 0.73% | -2.03% | -2.87% | 5.24% | -4.94% |
| Net Income Per EBT | 71.58% | 81.04% | 94.63% | 296.66% | 103.12% |
| EBT Per EBIT | 38.74% | -194.14% | -496.14% | 41.22% | 112.20% |
| Return on Assets (ROA) | 0.70% | -1.18% | -1.91% | 3.41% | -3.05% |
| Return on Equity (ROE) | 1.92% | -3.13% | -5.42% | 8.79% | -8.48% |
| Return on Capital Employed (ROCE) | 3.88% | 1.17% | 0.80% | 5.38% | -5.34% |
| Return on Invested Capital (ROIC) | 1.58% | 0.89% | 0.49% | 3.29% | -3.12% |
| Return on Tangible Assets | 0.70% | -1.18% | -1.92% | 3.42% | -3.05% |
| Earnings Yield | 3.02% | -4.98% | -5.55% | 7.53% | -4.26% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.19 | 4.42 | 5.06 | 5.16 | 5.00 |
| Payables Turnover | 5.73 | 4.69 | 4.43 | 4.72 | 5.53 |
| Inventory Turnover | 2.27 | 2.49 | 2.45 | 2.89 | 2.90 |
| Fixed Asset Turnover | 1.18 | 1.15 | 1.21 | 1.07 | 0.96 |
| Asset Turnover | 0.72 | 0.72 | 0.72 | 0.66 | 0.62 |
| Working Capital Turnover Ratio | -23.49 | -7.89 | -4.52 | -3.55 | -3.05 |
| Cash Conversion Cycle | 183.79 | 151.11 | 138.65 | 119.89 | 132.95 |
| Days of Sales Outstanding | 87.02 | 82.56 | 72.09 | 70.67 | 72.94 |
| Days of Inventory Outstanding | 160.51 | 146.42 | 148.93 | 126.51 | 125.98 |
| Days of Payables Outstanding | 63.75 | 77.87 | 82.36 | 77.29 | 65.97 |
| Operating Cycle | 247.54 | 228.98 | 221.01 | 197.18 | 198.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -50.19 | -39.95 | -153.82 | 161.95 | 25.29 |
| Free Cash Flow Per Share | -249.23 | -81.85 | -242.62 | 104.33 | 14.21 |
| Dividend Paid and CapEx Coverage Ratio | -0.25 | -0.95 | -1.73 | 2.81 | 2.28 |
| Capital Expenditure Coverage Ratio | -0.25 | -0.95 | -1.73 | 2.81 | 2.28 |
| Operating Cash Flow Coverage Ratio | -0.02 | -0.02 | -0.06 | 0.07 | 0.01 |
| Operating Cash Flow to Sales Ratio | -0.01 | -0.01 | -0.03 | 0.04 | 0.01 |
| Free Cash Flow Yield | -13.47% | -4.50% | -10.03% | 3.38% | 0.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 32.63 | -20.07 | -18.01 | 13.28 | -23.50 |
| Price-to-Sales (P/S) Ratio | 0.32 | 0.33 | 0.48 | 0.69 | 1.16 |
| Price-to-Book (P/B) Ratio | 0.64 | 0.63 | 0.98 | 1.17 | 1.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.42 | -22.22 | -9.97 | 29.62 | 332.93 |
| Price-to-Operating Cash Flow Ratio | -36.86 | -45.53 | -15.73 | 19.08 | 187.02 |
| Price-to-Earnings Growth (PEG) Ratio | -0.20 | 0.62 | 0.11 | -0.06 | 0.30 |
| Enterprise Value Multiple | 15.36 | 25.39 | 36.24 | 17.29 | 686.86 |
| Enterprise Value | 155.61B | 144.02B | 164.02B | 182.76B | 237.22B |
| EV to EBITDA | 15.36 | 25.39 | 36.24 | 17.29 | 686.86 |
| EV to Sales | 0.80 | 0.77 | 0.97 | 1.20 | 1.72 |
| EV to Free Cash Flow | -18.39 | -52.55 | -20.07 | 51.82 | 493.91 |
| EV to Operating Cash Flow | -91.32 | -107.66 | -31.66 | 33.38 | 277.45 |
| Tangible Book Value Per Share | 3062.60 | 3063.87 | 2627.36 | 2808.66 | 2532.89 |
| Shareholders’ Equity Per Share | 2908.16 | 2892.38 | 2477.89 | 2648.13 | 2374.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.46 | -0.01 | -0.02 | -2.01 | -0.03 |
| Revenue Per Share | 5750.51 | 5567.96 | 5034.80 | 4500.26 | 4075.04 |
| Net Income Per Share | 55.82 | -90.62 | -134.35 | 232.74 | -201.27 |
| Tax Burden | 0.72 | 0.81 | 0.95 | 2.97 | 1.03 |
| Interest Burden | 0.39 | -2.33 | -13.44 | 0.42 | 1.93 |
| Research & Development to Revenue | 0.05 | 0.01 | 0.02 | 0.01 | 0.01 |
| SG&A to Revenue | 0.39 | 0.44 | 0.43 | 0.31 | 0.33 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.90 | 0.35 | 1.14 | 0.69 | -0.13 |
Currency in KRW

